Literature DB >> 28616749

miR-183 and miR-21 expression as biomarkers of progression and survival in tongue carcinoma patients.

Gordana Supic1,2, Katarina Zeljic3, Aleksandra Divac Rankov4, Ruzica Kozomara5,6, Aleksandra Nikolic4, Dragica Radojkovic4, Zvonko Magic5,7.   

Abstract

OBJECTIVES: Micro RNAs (miRNAs) have a major role in human cancerogenesis.The current study investigated the prognostic significance of miR-183 and miR-21 expression in tongue carcinoma patients. MATERIAL AND
METHOD: For qPCR of miR-183 and miR-21 expression, total RNA isolated from 60 fresh-frozen tissue of tongue carcinomas was converted into cDNA by TaqMan MicroRNA Reverse Transcription Kit and quantified by TaqMan MicroRNAs Expression Assays. Fold changes in the miRNAs expression, normalized to RNU6B, were determined using 2-ΔΔCt method, and dichotomized into high and low according to cut-off values derived from ROC curve analysis.
RESULTS: miR-183 emerged as promising discriminatory biomarker of poor outcome. Tissue over-expression of miR-183, observed in 68.3% of tongue carcinomas, was associated with clinical stage (p = 0.037), tumor size (p = 0.036), and high alcohol intake (p = 0.034).The patients with miR-183 over-expression had significantly shorter overall survival (p = 0.006) and a 5.666 times higher risk of poor outcome (p = 0.005), while miR-21 over-expression carried a tendency towards poorer survival (p = 0.073). However, multivariate analysis revealed that the recurrences were independent adverse prognostic factors, while miR-183 over-expression lost its significance.
CONCLUSION: Our results suggests that over-expression of miR-183 in tumor tissue could be a potential marker of clinical stage and a poor survival of tongue carcinoma patients and may be associated with high alcohol consumption. CLINICAL RELEVANCE: Oncogenic miRNAs, such as the investigated miR-183 and miR-21, could be novel prognostic biomarkers of tumor progression and adverse clinical outcome in oral cancer, as well as novel therapeutic targets in cancer.

Entities:  

Keywords:  Oral cancer; Overall survival; Tongue carcinoma; miR-183; miR-21; microRNAs

Mesh:

Substances:

Year:  2017        PMID: 28616749     DOI: 10.1007/s00784-017-2126-y

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  52 in total

Review 1.  The epigenetics of oral cancer.

Authors:  R Shaw
Journal:  Int J Oral Maxillofac Surg       Date:  2005-09-08       Impact factor: 2.789

2.  Wnt/β-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.

Authors:  Wilson K C Leung; Mian He; Anthony W H Chan; Priscilla T Y Law; Nathalie Wong
Journal:  Cancer Lett       Date:  2015-03-23       Impact factor: 8.679

Review 3.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.

Authors:  O A Kent; J T Mendell
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

4.  MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.

Authors:  Deepak Abraham; Nicole Jackson; Justin S Gundara; JingTing Zhao; Anthony J Gill; Leigh Delbridge; Bruce G Robinson; Stan B Sidhu
Journal:  Clin Cancer Res       Date:  2011-05-27       Impact factor: 12.531

5.  Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.

Authors:  Jin-Feng Tang; Zhong-Hua Yu; Tie Liu; Zi-Ying Lin; Ya-Hong Wang; La-Wei Yang; Hui-Juan He; Jun Cao; Hai-Li Huang; Gang Liu
Journal:  Asian Pac J Cancer Prev       Date:  2014

6.  MicroRNA expression in head and neck cancer associates with alcohol consumption and survival.

Authors:  Michele Avissar; Michael D McClean; Karl T Kelsey; Carmen J Marsit
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

Review 7.  Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.

Authors:  Shanthi Marur; Arlene A Forastiere
Journal:  Mayo Clin Proc       Date:  2016-03       Impact factor: 7.616

8.  MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.

Authors:  Jinsong Li; Hongzhang Huang; Lijuan Sun; Mei Yang; Chaobin Pan; Weiliang Chen; Donghui Wu; Zhaoyu Lin; Chunxian Zeng; Yandan Yao; Peter Zhang; Erwei Song
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

9.  miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis.

Authors:  Christoph A Gebeshuber; Kurt Zatloukal; Javier Martinez
Journal:  EMBO Rep       Date:  2009-02-27       Impact factor: 8.807

10.  Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.

Authors:  Shan-Shan Sun; Xuan Zhou; Yuan-Yuan Huang; Ling-Ping Kong; Mei Mei; Wen-Yu Guo; Ming-Hui Zhao; Yu Ren; Qiang Shen; Lun Zhang
Journal:  Mol Cancer       Date:  2015-12-21       Impact factor: 27.401

View more
  7 in total

Review 1.  Prospective applications of microRNAs in oral cancer.

Authors:  Chuan Fang; Yadong Li
Journal:  Oncol Lett       Date:  2019-08-16       Impact factor: 2.967

Review 2.  Insight toward the MicroRNA Profiling of Laryngeal Cancers: Biological Role and Clinical Impact.

Authors:  Takashi Takeuchi; Hiromichi Kawasaki; Amalia Luce; Alessia Maria Cossu; Gabriella Misso; Marianna Scrima; Marco Bocchetti; Filippo Ricciardiello; Michele Caraglia; Silvia Zappavigna
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

Review 3.  Prognostic Value of MiR-21: An Updated Meta-Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC).

Authors:  Alexandra Iulia Irimie-Aghiorghiesei; Cecilia Pop-Bica; Sebastian Pintea; Cornelia Braicu; Roxana Cojocneanu; Alina-Andreea Zimța; Diana Gulei; Ondřej Slabý; Ioana Berindan-Neagoe
Journal:  J Clin Med       Date:  2019-11-21       Impact factor: 4.241

Review 4.  Aberrant Expression of microRNA Clusters in Head and Neck Cancer Development and Progression: Current and Future Translational Impacts.

Authors:  Li-Jie Li; Wei-Min Chang; Michael Hsiao
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-27

5.  MicroRNA meta-signature of oral cancer: evidence from a meta-analysis.

Authors:  Katarina Zeljic; Ivan Jovanovic; Jasmina Jovanovic; Zvonko Magic; Aleksandra Stankovic; Gordana Supic
Journal:  Ups J Med Sci       Date:  2018-02-26       Impact factor: 2.384

Review 6.  MicroRNA-21 Expression as a Prognostic Biomarker in Oral Cancer: Systematic Review and Meta-Analysis.

Authors:  Mario Dioguardi; Francesca Spirito; Diego Sovereto; Mario Alovisi; Giuseppe Troiano; Riccardo Aiuto; Daniele Garcovich; Vito Crincoli; Luigi Laino; Angela Pia Cazzolla; Giorgia Apollonia Caloro; Michele Di Cosola; Lorenzo Lo Muzio
Journal:  Int J Environ Res Public Health       Date:  2022-03-14       Impact factor: 3.390

7.  Role of mir-33a, mir-203b, mir361-3p, and mir-424 in hepatocellular carcinoma

Authors:  Burhanettin Yalçınkaya; Esra Güzel; Didem Taştekin; Sadrettin Pençe
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.